| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 9.43M | 9.43M | 5.92M | 2.62M | 3.38M | 515.09K |
| Gross Profit | 1.13M | 1.13M | 988.66K | -395.63K | -10.95M | -1.05M |
| EBITDA | -19.58M | -19.58M | -11.24M | -14.59M | -15.17M | -16.72M |
| Net Income | -19.89M | -19.89M | -11.89M | -15.33M | -16.97M | -17.18M |
Balance Sheet | ||||||
| Total Assets | 35.10M | 35.10M | 8.08M | 6.35M | 14.82M | 13.59M |
| Cash, Cash Equivalents and Short-Term Investments | 8.93M | 8.93M | 2.99M | 1.84M | 7.11M | 7.95M |
| Total Debt | 12.19M | 12.19M | 1.11M | 2.13M | 1.42M | 322.36K |
| Total Liabilities | 20.28M | 20.28M | 7.04M | 7.07M | 7.41M | 4.15M |
| Stockholders Equity | 14.82M | 14.82M | 1.03M | -714.96K | 7.41M | 9.44M |
Cash Flow | ||||||
| Free Cash Flow | -29.63M | -29.63M | -7.13M | -11.64M | -10.76M | -9.06M |
| Operating Cash Flow | -14.72M | -14.72M | -6.23M | -10.72M | -9.68M | -9.04M |
| Investing Cash Flow | -15.04M | -15.04M | -1.07M | -754.47K | -2.44M | -25.11K |
| Financing Cash Flow | 36.20M | 36.20M | 8.58M | 5.78M | 11.32M | -449.40K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
55 Neutral | AU$46.93M | -6.08 | -67.76% | ― | 7.08% | 33.70% | |
53 Neutral | AU$89.34M | -102.17 | -1.75% | ― | -5.37% | -140.00% | |
53 Neutral | AU$21.86M | -8.01 | -63.81% | ― | ― | 52.66% | |
50 Neutral | AU$211.27M | -9.97 | -22.28% | ― | 16.47% | 29.53% | |
41 Neutral | AU$27.72M | -2.76 | -869.14% | ― | 340.27% | 19.44% | |
39 Underperform | AU$383.86M | -15.00 | -246.04% | ― | 36.97% | -25.00% |
Titomic Limited has disclosed a change in the holdings of director Dr Andreas Schwer, in line with ASX requirements. Following the conversion of 20,000,000 share rights into ordinary shares at no cash consideration, Dr Schwer’s direct holding increased from 10,215,384 to 32,215,384 ordinary shares, with no interests disposed for value. The transaction, which was not conducted during a closed trading period, reflects the vesting of equity-based incentives and further aligns the director’s interests with those of shareholders, potentially signaling confidence in the company’s long-term prospects.
The most recent analyst rating on (AU:TTT) stock is a Buy with a A$0.50 price target. To see the full list of analyst forecasts on Titomic Ltd stock, see the AU:TTT Stock Forecast page.
Titomic Ltd has applied for quotation on the ASX of 5 million new fully paid ordinary shares under its ticker code TTT, with the securities issued on 19 December 2025. The additional shares expand the company’s quoted capital base, which may have implications for existing shareholders through potential dilution while providing the company with greater flexibility for capital management and future corporate activities.
The most recent analyst rating on (AU:TTT) stock is a Buy with a A$0.50 price target. To see the full list of analyst forecasts on Titomic Ltd stock, see the AU:TTT Stock Forecast page.
Titomic Limited has applied to the ASX for quotation of 20 million new fully paid ordinary shares under its ticker TTT, with the securities issued on 19 December 2025. The additional quotation increases the company’s listed share count, potentially affecting its capital structure and liquidity, although the announcement does not disclose the specific purpose of the new shares or further implications for shareholders.
The most recent analyst rating on (AU:TTT) stock is a Buy with a A$0.50 price target. To see the full list of analyst forecasts on Titomic Ltd stock, see the AU:TTT Stock Forecast page.
Titomic Ltd has applied to the ASX for quotation of 804,518 new fully paid ordinary shares, issued to its managing director as part of their remuneration package. The share issue, approved at the company’s 25 November 2025 AGM, modestly increases the company’s quoted capital base and further aligns executive incentives with shareholders ahead of the next phase of the company’s development.
The most recent analyst rating on (AU:TTT) stock is a Buy with a A$0.50 price target. To see the full list of analyst forecasts on Titomic Ltd stock, see the AU:TTT Stock Forecast page.
Titomic Limited has applied to the ASX for quotation of 1.4 million new fully paid ordinary shares, to be issued on 19 December 2025. The additional securities, linked to a previously announced transaction, will expand the company’s quoted share capital and may modestly enhance liquidity in its stock, signalling ongoing capital management activity that could support its operational and strategic initiatives.
The most recent analyst rating on (AU:TTT) stock is a Buy with a A$0.50 price target. To see the full list of analyst forecasts on Titomic Ltd stock, see the AU:TTT Stock Forecast page.
Titomic Limited has notified the market of the issue of new unquoted equity securities, comprising 5 million share rights and 30 million options with various expiry dates, all issued on 19 December 2025. The move increases Titomic’s pool of incentive or contingent equity instruments and may signal ongoing use of equity-based compensation or financing structures, with potential implications for future dilution and the company’s capital management strategy.
The most recent analyst rating on (AU:TTT) stock is a Buy with a A$0.50 price target. To see the full list of analyst forecasts on Titomic Ltd stock, see the AU:TTT Stock Forecast page.
Titomic Limited has issued a range of new securities to its directors and executives, including 1.4 million shares under the second tranche of a July 2025 placement subscribed by several board members, as well as 20 million shares to director Andreas Schwer through the conversion of rights previously approved under a directors’ share plan. Managing director Jim Simpson received multiple equity-based incentives, comprising short-term incentive shares, the vesting and conversion of 5 million rights into ordinary shares, and the grant of 25 million options structured in three tranches, while director John Frewen was granted 5 million options as part of his remuneration package. The moves significantly increase insider equity holdings and align management and board incentives with shareholders, reinforcing Titomic’s capital structure and governance framework as it advances its cold spray additive manufacturing strategy across key industrial sectors.
The most recent analyst rating on (AU:TTT) stock is a Buy with a A$0.50 price target. To see the full list of analyst forecasts on Titomic Ltd stock, see the AU:TTT Stock Forecast page.
Titomic Limited has secured an Early Manufacturing Development (EMD) contract valued at USD 1.7 million with a leading defense prime contractor. This collaboration aims to develop innovative manufacturing approaches to accelerate production and improve supply-chain resilience for next-generation defense articles. The contract, to be fulfilled by mid-2026, will leverage Titomic’s proprietary cold-spray additive manufacturing systems, enhancing the company’s role as a strategic supplier in defense modernization initiatives.
The most recent analyst rating on (AU:TTT) stock is a Buy with a A$0.50 price target. To see the full list of analyst forecasts on Titomic Ltd stock, see the AU:TTT Stock Forecast page.
Titomic Limited has announced a change in the director’s interest notice involving Mr. Humphrey Nolan. The update reveals that Mr. Nolan has converted 35,000,000 share rights into ordinary shares, increasing his total holdings to 52,500,000 ordinary shares. This conversion reflects a strategic adjustment in Mr. Nolan’s investment within the company, potentially impacting the company’s governance and shareholder dynamics.
The most recent analyst rating on (AU:TTT) stock is a Buy with a A$0.50 price target. To see the full list of analyst forecasts on Titomic Ltd stock, see the AU:TTT Stock Forecast page.
Titomic Limited has issued 35 million fully paid ordinary shares to director Mr. Humphrey Nolan under a directors’ share plan approved by shareholders. These shares are subject to a 12-month voluntary escrow arrangement with Mr. Nolan, as the company explores potential near-term initiatives. This move reflects Titomic’s strategic efforts to strengthen its financial positioning while maintaining compliance with disclosure obligations.
The most recent analyst rating on (AU:TTT) stock is a Buy with a A$0.50 price target. To see the full list of analyst forecasts on Titomic Ltd stock, see the AU:TTT Stock Forecast page.
Titomic Ltd has announced the issuance of 35 million fully paid ordinary shares, which will be quoted on the Australian Securities Exchange (ASX) under the code TTT. This move is part of the company’s strategy to enhance its capital structure and potentially expand its market presence, reflecting a significant step in its growth trajectory and offering potential implications for investors and stakeholders.
The most recent analyst rating on (AU:TTT) stock is a Buy with a A$0.50 price target. To see the full list of analyst forecasts on Titomic Ltd stock, see the AU:TTT Stock Forecast page.
Titomic Limited has secured a contract valued at 135,000 Euros for its medium pressure Titomic TKF™ 623 system from the Institute for Sustainability and Innovation in Structural Engineering (ISISE) in Portugal. This deal marks Titomic’s first order in Portugal and highlights its commitment to expanding its technology’s reach across various industries, particularly in the Oil and Gas sector, where its solutions will aid in corrosion protection and other applications. The collaboration with ISISE, a prominent research center in civil and structural engineering, is expected to enhance Titomic’s market positioning and drive strategic growth in the structural engineering field.
The most recent analyst rating on (AU:TTT) stock is a Buy with a A$0.50 price target. To see the full list of analyst forecasts on Titomic Ltd stock, see the AU:TTT Stock Forecast page.
Titomic Limited has secured its first Low Rate Initial Production (LRIP) order for specialized components in the semiconductor industry, marking a significant commercial milestone. This order, following the successful validation of its Titomic Kinetic Fusion™ process, positions the company to expand its presence in high-performance manufacturing sectors. The LRIP phase is crucial for transitioning to full-scale production, with expectations for further orders in 2026 to be fulfilled at its advanced facility in the Netherlands. This development underscores Titomic’s strategy of targeting high-value, technologically demanding markets and reflects growing market confidence in its capabilities.
The most recent analyst rating on (AU:TTT) stock is a Buy with a A$0.50 price target. To see the full list of analyst forecasts on Titomic Ltd stock, see the AU:TTT Stock Forecast page.
Titomic Limited has successfully completed a hot fire test on a solid rocket motor thrust chamber manufactured using its Titomic Kinetic Fusion™ technology for a major U.S. aerospace and defense prime. This milestone validates the capability of Titomic’s cold spray additive manufacturing to produce high-performance components for aerospace and defense applications, demonstrating exceptional structural integrity and thermal resilience. The achievement underscores the transformative potential of Titomic’s technology in the aerospace and defense sectors, offering rapid production of complex geometries with improved material properties and reduced lead times. This success strengthens Titomic’s position in the market and aligns with its strategy to expand its presence in the Department of Defense and foster partnerships with major defense primes.
The most recent analyst rating on (AU:TTT) stock is a Sell with a A$0.18 price target. To see the full list of analyst forecasts on Titomic Ltd stock, see the AU:TTT Stock Forecast page.
Titomic Limited announced the successful results of its Annual General Meeting, where all resolutions were carried on a poll. This outcome reflects strong shareholder support for the company’s strategic decisions and governance, potentially reinforcing its position in the additive manufacturing industry. The resolutions passed are expected to positively impact Titomic’s operational and strategic initiatives, benefiting stakeholders and enhancing the company’s market positioning.
The most recent analyst rating on (AU:TTT) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Titomic Ltd stock, see the AU:TTT Stock Forecast page.
Titomic Limited’s recent AGM presentation highlights the company’s strategic direction and operational updates. The presentation underscores Titomic’s commitment to driving innovation and securing its future growth through its proprietary technologies. The company acknowledges the inherent risks and uncertainties in its operations and emphasizes the need for investors to consider these factors carefully. The presentation also notes that Titomic’s forward-looking statements are subject to change and should not be solely relied upon for investment decisions.
The most recent analyst rating on (AU:TTT) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Titomic Ltd stock, see the AU:TTT Stock Forecast page.
Titomic Limited has announced the cessation of certain securities, specifically 571,500 options that were set to expire on June 20, 2032. These securities have lapsed due to the conditions for their issuance not being met or becoming incapable of being satisfied, impacting the company’s issued capital.
The most recent analyst rating on (AU:TTT) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Titomic Ltd stock, see the AU:TTT Stock Forecast page.
Titomic Limited has announced a change in its financial year-end from June 30 to December 31, aligning its reporting period with its U.S. and European operations. This adjustment is expected to streamline the company’s financial reporting and enhance operational coherence across its international markets.
The most recent analyst rating on (AU:TTT) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Titomic Ltd stock, see the AU:TTT Stock Forecast page.
Titomic Ltd has announced significant developments in its global operations, including the launch of a new state-of-the-art manufacturing facility in Heerenveen, Netherlands, and the establishment of a subsidiary in the United Kingdom. These expansions aim to enhance Titomic’s service capabilities and market presence in Europe and the UK, supporting industries with advanced cold spray technology solutions. Additionally, the company has raised A$50 million to accelerate its global expansion and formed strategic partnerships to bolster its manufacturing and innovation efforts. These initiatives are expected to strengthen Titomic’s industry positioning and support its growth strategy, with potential implications for stakeholders in terms of improved service delivery and technological advancements.
The most recent analyst rating on (AU:TTT) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Titomic Ltd stock, see the AU:TTT Stock Forecast page.
Titomic Limited has announced the details for its 2025 Annual General Meeting (AGM), which will be held virtually on November 25, 2025. Shareholders can participate online, ask questions, and vote in real-time, with voting open until November 23, 2025. This virtual format aims to enhance shareholder engagement and participation, reflecting the company’s commitment to leveraging technology to improve stakeholder interaction.
The most recent analyst rating on (AU:TTT) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Titomic Ltd stock, see the AU:TTT Stock Forecast page.
Titomic Limited has announced a lease agreement for its D623 medium-pressure cold spray system with an Australian energy provider for use on oil and gas rigs on the North West Shelf. This agreement, generating AUD 73,000 in revenue, marks a significant validation of Titomic’s technology in live offshore operations, enhancing its position in the Oil & Gas and maritime markets. The deployment of the D623 system, which follows a successful trial of a smaller model, demonstrates the system’s capability to deliver high-performance coatings and repairs, thus reducing downtime and maintenance costs in harsh environments. The collaboration is expected to open further opportunities for Titomic in the energy sector, highlighting the company’s strategic expansion and the growing confidence in its transformative solutions.
The most recent analyst rating on (AU:TTT) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Titomic Ltd stock, see the AU:TTT Stock Forecast page.
Titomic Ltd has announced the issuance of 9,437,142 fully paid ordinary shares, including 9,161,019 shares allocated to employees as part of the final tranche of a company-wide incentive program, and 276,123 shares issued to a senior employee for long-term contributions. This move is part of Titomic’s strategy to incentivize its workforce and recognize key contributions, potentially strengthening its operational capabilities and market position.
The most recent analyst rating on (AU:TTT) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Titomic Ltd stock, see the AU:TTT Stock Forecast page.
Titomic Limited has announced the issuance of 9,437,142 ordinary shares to its employees, effective October 10, 2025. This includes 9,161,019 shares as part of the final tranche of a company-wide employee share rights plan initiated in September 2023, and 276,123 shares granted to a senior employee for long-term contribution. This move is expected to strengthen employee engagement and align their interests with the company’s growth objectives.
The most recent analyst rating on (AU:TTT) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Titomic Ltd stock, see the AU:TTT Stock Forecast page.
Titomic Ltd has announced the quotation of 2,000,000 fully paid ordinary securities on the Australian Securities Exchange (ASX) under the code TTT. This move is part of their strategy to enhance liquidity and provide more opportunities for investment, potentially strengthening their market position and offering benefits to stakeholders.
The most recent analyst rating on (AU:TTT) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Titomic Ltd stock, see the AU:TTT Stock Forecast page.
Titomic Ltd has announced a proposed institutional placement of new fully paid ordinary shares to sophisticated and professional investors. This move is aimed at raising capital to support the company’s growth and operational strategies. The placement is not underwritten and will be managed by a syndicate of bookrunners and joint lead managers. This strategic financial maneuver is expected to enhance Titomic’s market position and provide the necessary funds to drive innovation and secure future business opportunities.
The most recent analyst rating on (AU:TTT) stock is a Buy with a A$0.50 price target. To see the full list of analyst forecasts on Titomic Ltd stock, see the AU:TTT Stock Forecast page.